Several studies have shown that STING pathway activation could stimulate anti-inflammatory T cell responses via the induction of indoleamine 2,3 dioxygenase (IDO), which could in turn cause immune suppression in the tumor microenvironment [54,55,56,57,58]. This evidence concerns the gene IDO1 and neoplasm.